Authors: | Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; Ahsanuddin, S.; Callan, D.; Freidin, B.; Porzio, R.; Dang, T. O.; Ni, A.; Rademaker, J.; Schoder, H.; Dogan, A.; Younes, A. |
Abstract Title: | Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL) |
Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
Journal Title: | Journal of Clinical Oncology |
Volume: | 35 |
Issue: | 15 Suppl. |
Meeting Dates: | 2017 Jun 2-6 |
Meeting Location: | Chicago, IL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2017-05-20 |
Start Page: | 403s |
Language: | English |
ACCESSION: | WOS:000411931709031 |
DOI: | 10.1200/JCO.2017.35.15_suppl.7544 |
PROVIDER: | wos |
Notes: | Meeting Abstract: 7544 -- Source: Wos |